SCHEMBL9895023

SCHEMBL9895023

CS(=O)(=O)c1ccc(C(Cc2ccc(F)cc2)C(=O)Nc2nc3ccccc3o2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.45
CSNK1D P48730 1/20 0.43
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
GCK P35557 3/20 0.42
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CTSS P25774 1/20 0.40
PTGS2 P35354 1/20 0.40
PTPN2 P17706 3/20 0.39
HSPD1 P10809 1/20 0.39
PTPN5 P54829 1/20 0.39
HSPE1 P61604 1/20 0.39
GALK1 P51570 1/20 0.39
FFAR2 O15552 1/20 0.38
SCD O00767 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9895818 1.00 PTPN1 (0.45) PTPN1CSNK1DKMT2AMAPTGCK
SCHEMBL9895215 0.92 NPC1 (0.44) PTPN1CSNK1DKMT2AGCKNPC1
SCHEMBL9896000 0.91 AKT1 (0.43) PTPN1KMT2AMAPTGCKCTSS
SCHEMBL9897188 0.91 PTPN2 (0.46) PTPN1CSNK1DKMT2AMAPTGCK
SCHEMBL9896229 0.91 CSNK1D (0.50) PTPN1CSNK1DKMT2AMAPTNPC1
SCHEMBL9894828 0.90 FFAR2 (0.45) KMT2AMAPTGCKTP53SMN1; SMN2
SCHEMBL9894833 0.90 PTPN1 (0.43) PTPN1CSNK1DKMT2AMAPTNPC1
SCHEMBL9896267 0.89 SMN1; SMN2 (0.42) PTPN1CSNK1DKMT2AGCKNPC1
SCHEMBL9894922 0.89 XDH (0.41) PTPN1MAPTGCKTP53FFAR2
SCHEMBL9895191 0.89 GCK (0.40) PTPN1GCKCTSSGALK1FFAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US claimed
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 PTPN1 852/4885CSNK1D 2063/4885KMT2A 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.